• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

How Diagnostic Robotics Unlocks the Full Potential Value of Care Management

Article

Sponsored Content

Artificial intelligence (AI) is becoming a critical resource for health plans to reduce cost of care and improve patient outcomes. By proactively identifying members whose risk for adverse health events is preventable and who are likely to engage, AI models can help these plans understand where care management outreach has the most impact on lives, member satisfaction, and ROI.

Learn how a Diagnostic Robotics AI-powered solution helped Blue Cross Blue Shield of Rhode Island target members within its congestive heart failure (CHF) and spinal care (MSK) programs to identify avoidable surgeries and hospitalizations and drive significant cost savings.

Complete the form below to learn more.

Sponsored by

© 2024 MJH Life Sciences

All rights reserved.